GSK Settles 10,000 Avandia Cases For $460M
While the settlement resolves the majority of claims — at an average price of $46,000 apiece — 3,000 cases remain outstanding, Bloomberg News reported Tuesday, citing sources familiar with the agreement.
GSK spokeswoman Mary Anne Rhyne refused to either confirm or deny the deal. Attorneys representing plaintiffs in a multidistrict litigation consolidated...
To view the full article, register now.